Clinical Trial Update: Phase II Trial of RAD001 in Refractory Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II study of RAD001 (everolimus) in refractory colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Swedish Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED